{"id":280319,"date":"2021-03-25T09:00:17","date_gmt":"2021-03-25T08:00:17","guid":{"rendered":"http:\/\/innovationorigins.com\/?p=280319"},"modified":"2021-03-25T09:00:17","modified_gmt":"2021-03-25T08:00:17","slug":"sirius-pintuition-gets-clearance-for-use-in-united-states","status":"publish","type":"post","link":"https:\/\/ioplus.nl\/archive\/en\/sirius-pintuition-gets-clearance-for-use-in-united-states\/","title":{"rendered":"Sirius Pintuition gets clearance for use in United States"},"content":{"rendered":"\n<p><a href=\"https:\/\/innovationorigins.com\/clinical-tests-show-the-effect-and-safety-of-sirius-pintuition-in-breast-cancer-surgery\/\">The Sirius Pintuition<\/a>, a device that localizes breast cancer tumors using a magnetic seed, has been given clearance by the FDA (Food and Drug Administration) for use in the United States. This important milestone allows the Eindhoven-based <a href=\"https:\/\/www.sirius-medical.com\/\">Sirius Medical<\/a> to enter the US oncological surgery sector.<\/p>\n\n\n\n<p>\u201cWe are very proud to achieve this important milestone with our team in this short amount of time,\u201d says Barm Schermers, co-founder and inventor of Sirius Pintuition. \u201cIt\u2019s unbelievable to see that a small idea led to technology that will now become available in two continents across the globe.\u201d<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Minimizing harm in oncological surgery<\/h3>\n\n\n\n<p>A recent development in helping to remove abnormal breast tissue linked with tumors is a method known as <em>radioactive seed localization<\/em>. The method involves placing a tiny radioactive metal seed (about the size of a sesame seed) next to the abnormal tissue with a very fine needle. The seed can then be located with a hyper-sensitive sensor, allowing oncologists to remove only what they need to and minimizing the invasiveness of the surgery.<\/p>\n\n\n\n<p>The Sirius Pintuition uses a similar method but is novel in that it uses a magnetized &#8216;seed&#8217; with a specialized sensor to locate it. This means that it has the same effects of radioactive seed localization without the potentially adverse effects of a radioactive device placed in the body.<\/p>\n\n\n\n<p>The clearance means the US can join the other eight countries across Europe currently using the Sirius Pintuition.<\/p>\n\n\n\n<p>Hubert Martens, CEO and cofounder of Sirius: \u201cSirius Pintuition is an advanced system that allows surgeons to approach the tumor more freely, enabling the best possible outcome for patients.\u201d<\/p>\n\n\n\n<p><a href=\"https:\/\/innovationorigins.com\/cancer-treatment-of-the-future-will-outsmart-tumors\">Read more about innovation in cancer treatments<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Sirius Pintuition, a device that localizes breast cancer tumors using a magnetic seed, has been given clearance by the FDA (Food and Drug Administration) for use in the United States. This important milestone allows the Eindhoven-based Sirius Medical to enter the US oncological surgery sector. \u201cWe are very proud to achieve this important milestone [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":520319,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[34665],"tags":[31500,27509,59707,52921,52166,5878],"location":[6763],"article_type":[],"serie":[],"archives":[],"internal_archives":[],"reboot-archive":[],"class_list":["post-280319","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-fda-en","tag-newsletter-en","tag-oncology","tag-pintuition","tag-sirius-medical","tag-surgery","location-netherlands"],"blocksy_meta":[],"acf":{"subtitle":"With this clearance, Sirius Medical can now provide an alternative to other more invasive methods of imaging during oncological surgery.  ","text_display_homepage":false},"author_meta":{"display_name":"Alex Davidson","author_link":"https:\/\/ioplus.nl\/archive\/author\/alex-davidson\/"},"featured_img":"https:\/\/ioplus.nl\/archive\/wp-content\/uploads\/2020\/07\/Pintuition-Sirius-300x175.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">Health<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Health<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">FDA<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">Newsletter<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">oncology<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">Pintuition<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">Sirius Medical<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">surgery<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">FDA<\/span>","<span class=\"advgb-post-tax-term\">Newsletter<\/span>","<span class=\"advgb-post-tax-term\">oncology<\/span>","<span class=\"advgb-post-tax-term\">Pintuition<\/span>","<span class=\"advgb-post-tax-term\">Sirius Medical<\/span>","<span class=\"advgb-post-tax-term\">surgery<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 5 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on March 25, 2021","modified":"Updated on March 25, 2021"},"absolute_dates_time":{"created":"Posted on March 25, 2021 9:00 am","modified":"Updated on March 25, 2021 9:00 am"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/280319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/comments?post=280319"}],"version-history":[{"count":0,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/280319\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media\/520319"}],"wp:attachment":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media?parent=280319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/categories?post=280319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/tags?post=280319"},{"taxonomy":"location","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/location?post=280319"},{"taxonomy":"article_type","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/article_type?post=280319"},{"taxonomy":"serie","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/serie?post=280319"},{"taxonomy":"archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/archives?post=280319"},{"taxonomy":"internal_archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/internal_archives?post=280319"},{"taxonomy":"reboot-archive","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/reboot-archive?post=280319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}